Overview
AXQ Capital is a quantitative investment firm started in 2018 with offices in New York, Beijing, Shanghai, and Hong Kong. It uses systematic, data-driven models to generate investment ideas and execute trades across global markets, covering multiple asset classes and trading frequencies. The firm's product works by scientific research powering quantitative algorithms that produce alphas, which are implemented through automated trading systems. It differentiates itself through a strong emphasis on rigorous research and a global, cross-asset capability, supported by technology and reliable execution. The goal is to generate consistent alpha by combining advanced research with robust technology across diverse markets.
Work here?Claim your company
Simplify's Take
What believers are saying
- AXQ's disclosed long portfolio reached $919.7 million in Q2 2026.
- AXQ added Gilead and Westlake in Q2 2026, showing active capital deployment.
- The firm still expanded from 777 million to 919.7 million quarter over quarter.
What critics are saying
- Q2 2026 turnover hit 58.24%, which crushes edge and inflates trading costs.
- The disclosed book lagged the S&P 500 by 3.8% through June 2026.
- Persistent underperformance would drive allocator redemptions and pressure AXQ's $919.7 million platform.
What makes AXQ Capital unique
- Founded in 2018, AXQ runs global quant strategies across four offices.
- Q2 2026 13F showed 960 positions, signaling deep systematic diversification.
- AXQ combines U.S. equities with cross-market research from New York, Beijing, Shanghai, Hong Kong.
Help us improve and share your feedback! Did you find this helpful?